Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy

Author： Nair Jagdish R   Edwards Steven W   Moots Robert J  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.12, Iss.12, 2012-12, pp. : 1661-1668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal antibody treatments for rheumatoid arthritis

By Bossaller Lukas  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1257-1272

Informa Healthcare

Access to resources Recommend Favorite

cDNA Representational Difference Analysis of Human Neutrophils Stimulated by GM-CSF

By Yousefi S.   Cooper P.R.   Mueck B.   Potter S.L.   Jarai G.  

Biochemical and Biophysical Research Communications, Vol. 277, Iss. 2, 2000-10 ,pp. : 401-409

Elsevier

Access to resources Recommend Favorite

Therapeutic Use of a Mouse/Human Chimeric CD4 Antibody in Rheumatoid Arthritis

By Dalesandro M.R.   Kinney C.S.   Ghrayeb J.  

Methods, Vol. 8, Iss. 2, 1995-10 ,pp. : 157-165

Academic Press

Access to resources Recommend Favorite

Rabbit M1 and M2 macrophages can be induced by human recombinant GM‐CSF and M‐CSF

By  

FEBS Open Bio, Vol. 6, Iss. 9, 2016-09 ,pp. : 945-953

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alemtuzumab: a novel monoclonal antibody

By Keating Michael J   O’Brien Susan   Ferrajoli Alessandra  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 1059-1065

Informa Healthcare

Access to resources Recommend Favorite